Original Query: ALL
Previous Study | Return to List | Next Study

Pemoline for Cocaine Abuse - 7

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00000282
Recruitment Status : Completed
First Posted : September 21, 1999
Last Update Posted : December 15, 2016
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Information provided by (Responsible Party):
Yale University

Brief Summary:
The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.

Condition or disease Intervention/treatment Phase
Cocaine-Related Disorders Drug: Pemoline Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 0 participants
Primary Purpose: Treatment
Official Title: Pemoline for Cocaine Abuse
Study Start Date : September 1994
Primary Completion Date : August 1999
Study Completion Date : August 1999

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Side effects
  2. Drug use
  3. Retention

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Please contact site for information.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00000282

United States, Connecticut
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
Yale University
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Principal Investigator: Thomas R Kosten, M.D. VA Connecticut Healthcare System

J Psychoactive Drugs 28:301-304, 1996. Addictive Beh. 22, 1997. Am J Addiction 5, 275, 1996.

Responsible Party: Yale University Identifier: NCT00000282     History of Changes
Other Study ID Numbers: NIDA-09250-7
P50DA009250 ( U.S. NIH Grant/Contract )
First Posted: September 21, 1999    Key Record Dates
Last Update Posted: December 15, 2016
Last Verified: December 2016

Keywords provided by Yale University:

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Central Nervous System Stimulants